Stroke
Showing NaN - NaN of 12
Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)
Completed
- Stroke
- Secondary Prevention
- optional ASA as comedication
- +5 more
-
Phoenix, Arizona
- +568 more
Aug 13, 2019
Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (Botulinum Toxin Type A)
Completed
- Pediatrics
- +3 more
- Botulinum Toxin Type A
-
Pasadena, California
- +47 more
Jul 29, 2019
Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)
Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban
Completed
- Stroke
- +2 more
- warfarin tablets
- +4 more
-
Birmingham, Alabama
- +1015 more
Feb 8, 2019
Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)
Terminated
- Stroke
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Tucson, Arizona
- +453 more
Dec 20, 2018
Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (botulinum toxin Type A, Normal Saline (Placebo))
Completed
- Pediatrics
- +3 more
- botulinum toxin Type A
- Normal Saline (Placebo)
-
Pasadena, California
- +44 more
Jul 16, 2018
Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor
Completed
- Myocardial Infarction
- +3 more
- Ticagrelor 90 mg
- +2 more
-
Alexander City, Alabama
- +846 more
Dec 18, 2015
Atrial Fibrillation, Stroke, Embolism Trial in Worldwide (Rivaroxaban, Warfarin, Matching for Rivaroxaban arm (Warfarin ))
Completed
- Atrial Fibrillation
- +2 more
- Rivaroxaban
- +3 more
-
Birmingham, Alabama
- +958 more
Apr 10, 2014